We all have a unique face, fingerprint, voice, and signature, so why wouldn’t we have a unique response to the medicine and treatments we receive? Mark Hitchman, Managing Director at Canon Medical Systems UK, explores this question.
Scientists from Boston University (BU) and the Wyss Institute at Harvard University have developed a new method called ESCAPE, which is engineered sacrificial capillary pumps for evacuation that could improve how tissue is fabricated and designed.
As Emergency Departments face increasing pressure, more patients are being redirected for minor injuries. While this eases the burden, missed fractures are on the rise, causing the NHS to lose millions in misdiagnosis costs.
Researchers at Queen Mary University of London have made a significant breakthrough in the early prediction of dementia, developing a new method that can predict the disease with over 80% accuracy up to nine years before a clinical diagnosis.
NHS patients in England are set to gain quicker access to the latest and most innovative medical technologies, thanks to new plans proposed by NHS England and the National Institute for Health and Care Excellence (NICE).
With the potential to revolutionise medical diagnostics, a breathalyser using quantum laser-based technology could diagnose illness from exhaled breath.
Researchers have completed an advanced brain map on an insect, aiding future brain research and neuroscience in the understanding of the mechanism of thought.
Cancers that are starved of oxygen, otherwise known as hypoxic cancers, are generally difficult to identify – but medical imaging has taken a new step with the MR-Linac scanner.
Matthew Bradfield, Managing Director at Fairford Medical Ltd conducts a case study of Liverpool University Hospitals NHS Foundation Trust and its new CT scanner
In...
Remote healthcare communication tools can be highly effective and useful for collaboration, clinical assessments, and surgical training, finds Ingo Aicher, Managing Director at Jones AV Limited.
The Imaging and Radiation Oncology Core is part of the U.S. National Cancer Institute’s clinical trial program and provides quality assurance for trials with radiation oncology and/or imaging.
Dr Dan Williams, SynaptixBio CEO, discusses the search to find the first treatment for one of the world’s rarest diseases, TUBB4A-associated leukodystrophy
Researchers from Kyoto University Hospital and Preemptive Medicine and Lifestyle Related Disease Research Center, describe the future of vascular imaging technology, including how photoacoustic imaging targets tumour vessels in breast cancer.
